
Passage Bio PASG
$ 3.94
12.25%
Passage Bio EV - Enterprise Value | PASG
Annual EV - Enterprise Value Passage Bio
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.3 M | 24 M | 4.93 M | 111 M | 73.4 M | 176 M | 335 M | -155 M | 45.6 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 335 M | -155 M | 70.1 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Inhibrx
INBX
|
1.73 B | $ 68.81 | -7.43 % | $ 3.24 B | ||
|
Scholar Rock Holding Corporation
SRRK
|
4.92 B | $ 48.09 | -4.54 % | $ 5.52 B | ||
|
Revolution Medicines
RVMD
|
19.9 B | $ 161.01 | 0.99 % | $ 30.6 B | ||
|
Entera Bio Ltd.
ENTX
|
85.4 M | $ 3.29 | 0.15 % | $ 152 M | ||
|
Flexion Therapeutics, Inc.
FLXN
|
1.49 B | - | - | $ 459 M | ||
|
Legend Biotech Corporation
LEGN
|
6.74 B | $ 15.21 | -5.53 % | $ 5.61 B | ||
|
CytomX Therapeutics
CTMX
|
971 M | $ 2.04 | -0.73 % | $ 281 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-22 M | $ 2.67 | 2.9 % | $ 1.81 M | ||
|
Krystal Biotech
KRYS
|
8.08 B | $ 308.83 | -2.21 % | $ 8.94 B | ||
|
Kura Oncology
KURA
|
1.15 B | $ 6.91 | -6.05 % | $ 606 M | ||
|
Inhibikase Therapeutics
IKT
|
-10.3 M | $ 1.31 | 0.38 % | $ 129 M | ||
|
Protara Therapeutics
TARA
|
208 M | $ 2.28 | -5.21 % | $ 97.7 M | ||
|
Heron Therapeutics
HRTX
|
411 M | $ 0.25 | -5.3 % | $ 41.7 M | ||
|
Inovio Pharmaceuticals
INO
|
104 M | $ 1.76 | 2.63 % | $ 82.5 M | ||
|
Corvus Pharmaceuticals
CRVS
|
324 M | $ 9.66 | -3.5 % | $ 763 M | ||
|
Aytu BioScience
AYTU
|
1.16 M | $ 2.66 | -0.37 % | $ 32.8 M | ||
|
Heat Biologics, Inc.
HTBX
|
4.26 B | - | -5.76 % | $ 99.8 M | ||
|
Innoviva
INVA
|
1.07 B | $ 18.42 | 0.03 % | $ 1.24 B | ||
|
BioCardia
BCDA
|
8.09 M | $ 0.77 | -0.08 % | $ 5.13 M | ||
|
Bio-Techne Corporation
TECH
|
11 B | $ 72.69 | -0.01 % | $ 11.3 B | ||
|
Kindred Biosciences, Inc.
KIN
|
20.2 B | - | 0.11 % | $ 419 M | ||
|
Alterity Therapeutics Limited
ATHE
|
29.4 B | $ 1.52 | -8.16 % | $ 9.72 B | ||
|
Shineco, Inc.
TYHT
|
22.9 B | - | -3.90 % | $ 97.2 M | ||
|
ORIC Pharmaceuticals
ORIC
|
1 B | $ 7.34 | -4.68 % | $ 644 M | ||
|
Millendo Therapeutics, Inc.
MLND
|
31.7 B | - | -5.36 % | $ 20.2 M | ||
|
Certara
CERT
|
1.38 B | $ 10.56 | -1.12 % | $ 1.69 B | ||
|
Intec Pharma Ltd
NTEC
|
2.88 B | - | -12.45 % | $ 17.7 M | ||
|
Anika Therapeutics
ANIK
|
156 M | $ 13.26 | -0.15 % | $ 190 M | ||
|
Aprea Therapeutics
APRE
|
-9.63 M | $ 0.23 | -52.81 % | $ 1.5 M | ||
|
Galectin Therapeutics
GALT
|
306 M | $ 2.68 | -4.63 % | $ 171 M | ||
|
Processa Pharmaceuticals
PCSA
|
837 K | $ 1.59 | -5.92 % | $ 2.08 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
3.82 B | $ 63.61 | -2.11 % | $ 6.61 B | ||
|
Progenity, Inc.
PROG
|
225 M | - | -3.47 % | $ 164 M | ||
|
Genprex
GNPX
|
-3.98 M | $ 1.46 | -12.87 % | $ 1.36 M | ||
|
Strongbridge Biopharma plc
SBBP
|
32.8 B | - | 1.52 % | $ 136 M | ||
|
Nektar Therapeutics
NKTR
|
1.27 B | $ 30.23 | -7.1 % | $ 510 M | ||
|
Innate Pharma S.A.
IPHA
|
98.2 M | $ 0.87 | -7.57 % | $ 77.9 M | ||
|
Seneca Biopharma, Inc.
SNCA
|
2.82 B | - | -1.19 % | $ 28.7 M | ||
|
BioMarin Pharmaceutical
BMRN
|
11.9 B | $ 60.42 | -1.64 % | $ 11.6 B | ||
|
Matinas BioPharma Holdings
MTNB
|
1.12 M | $ 0.75 | -9.23 % | $ 4.11 M | ||
|
Enanta Pharmaceuticals
ENTA
|
413 M | $ 7.6 | -4.82 % | $ 220 M | ||
|
Milestone Pharmaceuticals
MIST
|
143 M | $ 0.38 | -5.66 % | $ 40.4 M | ||
|
Lipocine
LPCN
|
15.2 M | $ 1.47 | -2.33 % | $ 8.01 M | ||
|
Seres Therapeutics
MCRB
|
110 M | $ 1.25 | -6.02 % | $ 11.1 M | ||
|
Oramed Pharmaceuticals
ORMP
|
91.5 M | $ 3.58 | -2.98 % | $ 148 M | ||
|
Madrigal Pharmaceuticals
MDGL
|
10.3 B | $ 378.19 | -4.68 % | $ 8.48 B | ||
|
CEL-SCI Corporation
CVM
|
21.1 M | $ 1.2 | -18.37 % | $ 9.62 M | ||
|
Inventiva S.A.
IVA
|
313 M | $ 3.14 | -9.13 % | $ 188 M | ||
|
MeiraGTx Holdings plc
MGTX
|
835 M | $ 7.98 | -1.97 % | $ 642 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
70.6 B | $ 39.21 | 1.76 % | $ 44.9 B |